Atlas Trials

Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

Clinical trial NCT01160991 · COMPLETED

Trial details

NCT number
NCT01160991
Sponsor
Central Institute of Mental Health, Mannheim
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaDiabetesInsulin Resistance
Start date
2004-05-01
Primary completion
2006-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.